Gabapentin
Product Images NDC 43353-872

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 43353-872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 600mg (43353 0872 70)

GABAPENTIN 600 mg tablets label from Aphena Pharma Solutions - Tennessee, LLC. The label specifies NDC 43353-0872, package count of 120 tablets. Storage instructions indicate 20-25 degrees Celsius, sealed in a light-resistant container. Manufactured by Invagen Pharmaceuticals Inc., distributed by Aphena Pharma in Cookeville, TN. Includes Barcode, lot number, and expiration date.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Image (Gabapentin 05)

A line graph showing mean pain scores over 8 weeks comparing placebo and gabapentin 3600 mg/day. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores. Gabapentin data show a decreasing trend, while placebo is relatively stable.*

FDA Label Image

Image (Gabapentin 06)

This line graph depicts mean pain scores over a 7-week period comparing placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day). It includes a 3-week dose titration period followed by a 4-week fixed dose period, illustrating changes in pain scores for each group across weeks.*

FDA Label Image

Image (Gabapentin 07)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares responder percentages between placebo (PBO) and gabapentin (GBP) at different doses (3600 mg, 1800 mg, 2400 mg) across two studies, with statistical significance noted (p < 0.01, p < 0.001).*

FDA Label Image

Image (Gabapentin 08)

A scatter plot chart illustrating percentage difference versus daily dose (mg) for three studies labeled Study a, Study b, and Study c. The x-axis represents daily dose amounts (600, 900, 1200, 1800 mg), and the y-axis shows difference percentages ranging approximately from 2% to 22%. Each study is represented by distinct marker styles in the data points.*

FDA Label Image

Equation 1 (Image 01)

An illustration of the creatinine clearance (CLCr) formula used to estimate kidney function. The formula calculates CLCr by multiplying (140 minus age in years) by weight in kilograms, divided by 72 times serum creatinine in mg/dL, with a multiplier of 0.85 for female patients.*

FDA Label Image

Structure (Struct)

Chemical structure diagram showing the molecular arrangement of gabapentin with labeled functional groups including amino and carboxyl groups attached to a cyclohexane ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.